# What Is Ara-290?
Ara-290 is an erythropoietin-derived peptide studied for tissue research.
## Key Facts
- Type: EPO-derived peptide
- Research status: Preclinical / Laboratory research
- Molecular information: C53H84N14O21
- Available specifications: 30mg, 10mg
- Testing: HPLC, Mass Spectrometry
## Detailed Overview
Ara-290 is an 11-amino acid peptide derived from the structure of erythropoietin, lacking hematopoietic activity. It has been studied in tissue protection research for its effects on the innate inflammatory response and nerve cell protection. Published research has investigated its interactions with the innate repair receptor. RaySunPeptide supplies Ara-290 for qualified research and laboratory applications.
Ara-290 is an erythropoietin-derived peptide studied for tissue research. It is supplied by RaySunPeptide as a research-grade compound for qualified laboratory and research applications.
Published research on Ara-290 remains at the preclinical and laboratory investigation stage. Researchers studying Ara-290 have access to peer-reviewed publications through PubMed that document various aspects of its chemical properties and biological activity.
RaySunPeptide manufactures and supplies Ara-290 with the following quality assurances:
- **Purity**: ≥98% verified by HPLC
- **Testing**: Each batch undergoes HPLC and Mass Spectrometry analysis
- **Documentation**: Certificates of Analysis (COA) available upon request
- **Packaging**: Available in multiple vial configurations
> **Note**: Ara-290 is supplied for qualified research and laboratory purposes only. It is not intended for human consumption, therapeutic use, or any application outside of controlled research environments.
## References
- PubMed database (pubmed.ncbi.nlm.nih.gov) for peer-reviewed research publications on Ara-290
- RaySunPeptide product specifications and Certificates of Analysis
## Related Products
- [BPC 157](/products/bpc-157)
- [BPC 5mg + TB 5mg](/products/bpc-5mg-tb-5mg)
- [BPC 10mg + TB 10mg](/products/bpc-10mg-tb-10mg)
- [TB500(Thymosin B4 Acetate)](/products/tb500thymosin-b4-acetate)
## About RaySunPeptide
RaySunPeptide is a peptide manufacturer and supplier based in Southeast Asia, providing research-grade peptides, proteins, and related compounds for qualified research, laboratory, and B2B applications. All products undergo rigorous quality control testing and are supplied with Certificates of Analysis (COA).
What Is Ara-290?
Quick Answer
Ara-290 is an erythropoietin-derived peptide studied for tissue research.
Key Facts
- Type: EPO-derived peptide
- Research status: Preclinical / Laboratory research
- Molecular information: C53H84N14O21
- Available specifications: 30mg, 10mg
- Testing: HPLC, Mass Spectrometry